Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
June
11, 2007
Date
of
Report (date of earliest event reported)
(Exact
name of Registrant as specified in its charter)
|
Delaware
|
000-33477
|
77-0584301
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer
Identification
Number)
|
2525
Augustine Dr.
(Address
of principal executive offices, including zip
code)
(408)
919-8400
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the
following
provisions (see General Instruction A.2. below):
o
Written
communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting
material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
Item
5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers
On
June
11, 2007, Anders Frisk tendered his resignation as Executive Vice President
of
Genesis Microchip Inc., effective as of July 31, 2007.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
| |
GENESIS
MICROCHIP
INC. |
|
|
|
| |
By: |
/s/ Elias Antoun |
| |
Elias
Antoun |
| |
President
&
Chief Executive Officer |
Date:
June 12, 2007